Your browser doesn't support javascript.
loading
Immunological control of ovarian carcinoma by chemotherapy and targeted anticancer agents.
Fucikova, Jitka; Palova-Jelinkova, Lenka; Klapp, Vanessa; Holicek, Peter; Lanickova, Tereza; Kasikova, Lenka; Drozenova, Jana; Cibula, David; Álvarez-Abril, Beatriz; García-Martínez, Elena; Spisek, Radek; Galluzzi, Lorenzo.
Afiliação
  • Fucikova J; Sotio, Prague, Czech Republic; Department of Immunology, Charles University, Second Faculty of Medicine and University Hospital Motol, Prague, Czech Republic. Electronic address: fucikova@sotio.com.
  • Palova-Jelinkova L; Department of Immunology, Charles University, Second Faculty of Medicine and University Hospital Motol, Prague, Czech Republic.
  • Klapp V; Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA.
  • Holicek P; Sotio, Prague, Czech Republic; Department of Immunology, Charles University, Second Faculty of Medicine and University Hospital Motol, Prague, Czech Republic.
  • Lanickova T; Sotio, Prague, Czech Republic; Department of Immunology, Charles University, Second Faculty of Medicine and University Hospital Motol, Prague, Czech Republic.
  • Kasikova L; Sotio, Prague, Czech Republic.
  • Drozenova J; Department of Pathology, Third Faculty of Medicine and University Hospital Kralovske Vinohrady, Prague, Czech Republic.
  • Cibula D; Gynecologic Oncology Center, Department of Obstetrics and Gynecology, Charles University, First Faculty of Medicine and General University Hospital, Prague, Czech Republic.
  • Álvarez-Abril B; Department of Hematology and Oncology, Hospital Universitario Morales Meseguer, Murcia, Spain.
  • García-Martínez E; Department of Hematology and Oncology, Hospital Universitario Morales Meseguer, Murcia, Spain; Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), Murcia, Spain; Universidad Católica San Antonio de Murcia, Guadalupe, Spain.
  • Spisek R; Sotio, Prague, Czech Republic; Department of Immunology, Charles University, Second Faculty of Medicine and University Hospital Motol, Prague, Czech Republic.
  • Galluzzi L; Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA; Sandra and Edward Meyer Cancer Centre, New York, NY, USA; Caryl and Israel Englander Institute for Precision Medicine, New York, NY, USA. Electronic address: deadoc80@gmail.com.
Trends Cancer ; 8(5): 426-444, 2022 05.
Article em En | MEDLINE | ID: mdl-35181272
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Antineoplásicos Limite: Female / Humans Idioma: En Revista: Trends Cancer Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Antineoplásicos Limite: Female / Humans Idioma: En Revista: Trends Cancer Ano de publicação: 2022 Tipo de documento: Article